Four global funds have submitted non-binding bids of ₹4,800-5,000 crore valuation. Final bids are likely to be in by June-end. The company had hired investment bank Avendus to find a buyer for the promoter’s stake.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SIYxR0
via IFTTT
0 comments:
Post a Comment